AMN Maintains Rating by BMO Capital -- Price Target Raised to $4
BMO Capital maintained an Outperform rating for AMN Healthcare Services (AMN) and raised its price target to $40.00 from $38.00. AMN is currently trading at $33.05, which is 11.2% above its GF Value™ of $29.71, indicating overvaluation. The company has a GF Score™ of 63, reflecting moderate performance, with strengths in profitability and financial strength but weaknesses in growth. Insiders have sold $114,369 worth of shares in the past three months.
How this was made
The 30-second read
Why it matters
Target increase signals a more favorable view but must be weighed against insider sales and valuation metrics.
Market read
Analyst target raise could prompt short‑term buying interest in AMN.
What to watch
Growth rank remains low (1/10) indicating potential earnings pressure.
Background
Analyst rating update from BMO Capital on AMN Healthcare Services.
Ticker impact
BMO Capital raised its price target for AMN to $40, up from $38.
Potential modest price gain toward $40 target.
Target raise reflects improved outlook; however, insider sell‑off and overvaluation concerns temper upside.
Market effects
May lift sentiment for healthcare staffing peers.
Limited to U.S. healthcare services sector.
Low
Counterpoint
Insider sell‑off and 11% overvaluation could outweigh the target raise.
Key entities
- companyAMN Healthcare Services
U.S. healthcare staffing provider (ticker AMN).
- analystBMO Capital
Research firm that raised the price target.
